Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 6, 2025Jan 6 6:05 PMBoughton Soleil
Proposed Sale
268,932$27.75$7.5M—

View →

Jan 2, 2025Jan 2 3:51 PMChi Michael
Proposed Sale
2,055$24.62$50.6K—

View →

Dec 24, 2024Dec 26 1:51 PMChi Michael
Proposed Sale
17,303$27.97$484.0K—

View →

Dec 20, 2024Dec 20 9:34 PMOluyemi Okupe
Proposed Sale
69,496$26.20$1.8M—

View →

Dec 19, 2024Dec 19 3:13 PMChi Michael
Proposed Sale
7,500$26.00$195.0K—

View →

Dec 17, 2024Dec 17 6:54 PMDudum Andrew
Proposed Sale
79,246$32.09$2.5M—

View →

Dec 17, 2024Dec 17 3:52 PMBecklund Irene
Proposed Sale
10,012$32.20$322.4K—

View →

Dec 17, 2024Dec 17 3:13 PMChi Michael
Proposed Sale
25,550$32.20$822.7K—

View →

Dec 16, 2024Dec 16 7:19 PMDudum Andrew
Proposed Sale
125,661$29.45$3.7M—

View →

Dec 16, 2024Dec 16 4:00 PMBecklund Irene
Proposed Sale
472$29.58$14.0K—

View →

Dec 10, 2024Dec 10 9:35 PMMelissa Baird
Proposed Sale
85,561$30.87$2.6M—

View →

Dec 10, 2024Dec 10 3:26 PMChi Michael
Proposed Sale
7,259$32.25$234.1K—

View →

Dec 2, 2024Dec 2 6:41 PMChi Michael
Proposed Sale
2,054$33.56$68.9K—

View →

Dec 2, 2024Dec 2 6:32 PMDudum Andrew
Proposed Sale
33,513$33.38$1.1M—

View →

Nov 26, 2024Nov 26 2:45 PMBoughton Soleil
Proposed Sale
2,343$29.90$70.1K—

View →

Nov 25, 2024Nov 25 5:20 PMChi Michael
Proposed Sale
17,303$26.49$458.4K—

View →

Nov 19, 2024Nov 19 6:50 PMChi Michael
Proposed Sale
7,500$22.00$165.0K—

View →

Nov 18, 2024Nov 18 10:15 PMMelissa Baird
Proposed Sale
58,750$20.99$1.2M—

View →

Nov 18, 2024Nov 18 4:46 PMBecklund Irene
Proposed Sale
472$19.42$9.2K—

View →

Nov 13, 2024Nov 13 11:27 PMOluyemi Okupe
Proposed Sale
189,150$27.60$5.2M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4